Transforming growth factor beta-induced dissociation between vitamin D receptor level and 1,25-dihydroxyvitamin D3 action in osteoblast-like cells. 1994

A Staal, and J C Birkenhäger, and H A Pols, and C J Buurman, and T Vink-van Wijngaarden, and W M Kleinekoort, and G J van den Bemd, and J P van Leeuwen
Department of Internal Medicine III, Erasmus University Medical School, Rotterdam, The Netherlands.

In the present study the interaction between a locally produced factor in bone, transforming growth factor beta (TGF beta) and a systemic regulator of bone metabolism, 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) was investigated. In rat (UMR 106, ROS 17/2.8) and human (MG-63) osteoblastic cell lines and in isolated fetal rat osteoblasts TGF beta caused a comparable increase in vitamin D receptor (VDR) level. A maximum was observed after 6 h at 1 ng/ml TGF beta. Scatchard analysis revealed that up-regulation of VDR is due to an increase in receptor number and not to a change in affinity. This was supported by Northern blot analysis which showed a dose- and time-dependent increase in VDR mRNA by TGF beta. To assess the significance of the TGF beta-induced increase in VDR level for 1,25-(OH)2D3 effects cells were preincubated with TGF for 4 h (causing a 2-3-fold increase of the VDR level) and subsequently incubated with 1,25-(OH)2D3 for 4 h and 24 h. TGF beta preincubation potently inhibited subsequent 1,25-(OH)2D3 stimulation of osteocalcin production in both ROS 17/2.8 and MG-63 cells on protein as well as mRNA level. A similar inhibition by TGF beta was observed on the 1,25-(OH)2D3-induced increase in osteopontin mRNA. The current study demonstrates dissociation between regulation of VDR level and modulation of two 1,25-(OH)2D3 biological responses by TGF beta in osteoblast-like cell lines of different origin. This dissociation shows that, besides interaction at VDR level also at other levels in the cell interaction(s) exist between TGF beta and 1,25-(OH)2D3. Besides, these data emphasize the potential importance of the interplay of locally produced factors and systemic calciotrophic hormones in the regulation of bone metabolism.

UI MeSH Term Description Entries
D010006 Osteoblasts Bone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone. Osteoblast
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D002117 Calcitriol The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption. 1 alpha,25-Dihydroxycholecalciferol,1 alpha,25-Dihydroxyvitamin D3,1, 25-(OH)2D3,1,25(OH)2D3,1,25-Dihydroxycholecalciferol,1,25-Dihydroxyvitamin D3,1 alpha, 25-dihydroxy-20-epi-Vitamin D3,1,25(OH)2-20epi-D3,1,25-dihydroxy-20-epi-Vitamin D3,20-epi-1alpha,25-dihydroxycholecaliferol,Bocatriol,Calcijex,Calcitriol KyraMed,Calcitriol-Nefro,Decostriol,MC-1288,MC1288,Osteotriol,Renatriol,Rocaltrol,Silkis,Sitriol,Soltriol,Tirocal,1 alpha,25 Dihydroxyvitamin D3,1,25 Dihydroxycholecalciferol,1,25 Dihydroxyvitamin D3,1,25 dihydroxy 20 epi Vitamin D3,Calcitriol Nefro,D3, 1 alpha,25-Dihydroxyvitamin,D3, 1,25-Dihydroxyvitamin,D3, 1,25-dihydroxy-20-epi-Vitamin,KyraMed, Calcitriol,MC 1288
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D012795 Sialoglycoproteins Glycoproteins which contain sialic acid as one of their carbohydrates. They are often found on or in the cell or tissue membranes and participate in a variety of biological activities. Polysialoglycoprotein,Sialoglycopeptide,Sialoglycopeptides,Sialoglycoprotein,Sialoprotein,Sialoproteins,Polysialoglycoproteins
D015152 Blotting, Northern Detection of RNA that has been electrophoretically separated and immobilized by blotting on nitrocellulose or other type of paper or nylon membrane followed by hybridization with labeled NUCLEIC ACID PROBES. Northern Blotting,Blot, Northern,Northern Blot,Blots, Northern,Blottings, Northern,Northern Blots,Northern Blottings

Related Publications

A Staal, and J C Birkenhäger, and H A Pols, and C J Buurman, and T Vink-van Wijngaarden, and W M Kleinekoort, and G J van den Bemd, and J P van Leeuwen
January 1994, Differentiation; research in biological diversity,
A Staal, and J C Birkenhäger, and H A Pols, and C J Buurman, and T Vink-van Wijngaarden, and W M Kleinekoort, and G J van den Bemd, and J P van Leeuwen
January 2001, Critical reviews in eukaryotic gene expression,
A Staal, and J C Birkenhäger, and H A Pols, and C J Buurman, and T Vink-van Wijngaarden, and W M Kleinekoort, and G J van den Bemd, and J P van Leeuwen
January 2004, The Journal of rheumatology,
A Staal, and J C Birkenhäger, and H A Pols, and C J Buurman, and T Vink-van Wijngaarden, and W M Kleinekoort, and G J van den Bemd, and J P van Leeuwen
November 1983, Molecular and cellular endocrinology,
A Staal, and J C Birkenhäger, and H A Pols, and C J Buurman, and T Vink-van Wijngaarden, and W M Kleinekoort, and G J van den Bemd, and J P van Leeuwen
April 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
A Staal, and J C Birkenhäger, and H A Pols, and C J Buurman, and T Vink-van Wijngaarden, and W M Kleinekoort, and G J van den Bemd, and J P van Leeuwen
January 1986, Journal of cellular physiology,
A Staal, and J C Birkenhäger, and H A Pols, and C J Buurman, and T Vink-van Wijngaarden, and W M Kleinekoort, and G J van den Bemd, and J P van Leeuwen
October 1987, The Journal of biological chemistry,
A Staal, and J C Birkenhäger, and H A Pols, and C J Buurman, and T Vink-van Wijngaarden, and W M Kleinekoort, and G J van den Bemd, and J P van Leeuwen
December 1995, Calcified tissue international,
A Staal, and J C Birkenhäger, and H A Pols, and C J Buurman, and T Vink-van Wijngaarden, and W M Kleinekoort, and G J van den Bemd, and J P van Leeuwen
March 1986, Endocrinology,
A Staal, and J C Birkenhäger, and H A Pols, and C J Buurman, and T Vink-van Wijngaarden, and W M Kleinekoort, and G J van den Bemd, and J P van Leeuwen
May 1989, Molecular and cellular endocrinology,
Copied contents to your clipboard!